Ansuvimab
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells[1].
Product Specifications
CAS Number
2375952-29-5
Product Name Alternative
Ansuvimab-zyk; mAb114
UNSPSC
12352203
Target
Filovirus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ansuvimab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Ansuvimab]
Molecular Weight
(143.94 kDa)
References & Citations
[1]Lee A, et, al. Ansuvimab: First Approval. Drugs. 2021 Apr;81 (5) :595-598.|[2]Corti D, et, al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016 Mar 18;351 (6279) :1339-42.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Isoform
ZEBOV
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
133566 100 µL
SMC3 (Structural Maintenance of Chromosomes Protein 3, SMC Protein 3, SMC-3, Basement Membrane-associated Chondroitin Proteoglycan, Bamacan, Chondroitin Sulfate Proteoglycan 6, Chromosome-associated Polypeptide, hCAP, BAM, BMH, CSPG6, SMC3L1) (Not for Export EU)
Sign In for Pricing
View Details 
